SALEM INVESTMENT COUNSELORS INC

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 884423 WINSTON-SALEM, NC

Position in BCRX

as of Mar 31, 2026 · filed Apr 29, 2026 Compact

Position Value

$1,904

+$386 QoQ

Shares Held

200

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

12 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

SALEM INVESTMENT COUNSELORS INC holds $527,346 across 13 Drug Manufacturers - Specialty & Generic names. BCRX ranks #8 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc	16,696	$225,562
2	HLN	Haleon plc	9,114	$91,231
3	ZTS	Zoetis Inc.	586	$69,271
4	DERM	Journey Medical Corp	14,300	$67,067
5	HROW	Harrow, Inc.	1,300	$45,838
6	HIMS	Hims & Hers Health, Inc.	1,025	$21,279
7	TLRY	Tilray Brands, Inc.	331	$2,141
8	BCRX	Biocryst Pharmaceuticals Inc This page	200	$1,904

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,904	200	0.0%	Shares	Sole	2026-04-29
2025-09-30	$1,518	200	0.0%	Shares	Sole	2025-10-07
2025-06-30	$1,792	200	0.0%	Shares	Sole	2025-07-08
2025-03-31	$1,500	200	0.0%	Shares	Sole	2025-04-16
2024-12-31	$1,504	200	0.0%	Shares	Sole	2025-01-13
2024-09-30	$1,520	200	0.0%	Shares	Sole	2024-10-15
2024-06-30	$1,236	200	0.0%	Shares	Sole	2024-07-11
2024-03-31	$1,016	200	0.0%	Shares	Sole	2024-04-11
2023-12-31	$1,198	200	0.0%	Shares	Sole	2024-01-16
2023-09-30	$1,416	200	0.0%	Shares	Sole	2023-10-04
2023-06-30	$1,408	200	0.0%	Shares	Sole	2023-07-19
2023-03-31	$1,668	200	—	Shares	Sole	2023-05-11
No filing history on record for this holder in this stock.